Helicobacter pylori reversing the landscape of neoadjuvant immunotherapy for microsatellite stable gastric cancer: a multicenter cohort study.

Tekijät: Hu C; Department of Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China., Liu H; Department of Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China., Hong B; Department of Pathology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China., Wang L; Department of Emergency Medicine, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China., Wu Z; Department of Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China., Xie W; Department of Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China., Luo B; Department of Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China., Cao D; Department of Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China.; Department of Gastrointestinal Surgery, Affiliated Hospital of Shaoxing University, Shaoxing City, China., Zhong Y; Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. zhongyuxin@cicams.ac.cn., Liu Y; Department of Gastric Surgery, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin, China. libraly@126.com., Gong W; Department of Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China. weihuagong@zju.edu.cn.

Lähde: BMC medicine [BMC Med] 2025 Apr 23; Vol. 23 (1), pp. 230. Date of Electronic Publication: 2025 Apr 23.

Julkaisutyyppi: Journal Article; Multicenter Study

Lehden tiedot: Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015 (Electronic) Linking ISSN: 17417015 NLM ISO Abbreviation: BMC Med Subsets: MEDLINE

MeSH-termit: Stomach Neoplasms*/therapy , Stomach Neoplasms*/microbiology , Stomach Neoplasms*/genetics , Helicobacter Infections*/complications , Helicobacter pylori* , Neoadjuvant Therapy*/methods , Immunotherapy*/methods , Adenocarcinoma*/therapy , Adenocarcinoma*/microbiology, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Aged ; China ; Adult ; Cohort Studies

Prolonged time interval from neoadjuvant immunotherapy combined with chemotherapy to surgery is related to unimproved pathological response and poor survival prognosis for esophageal squamous cell carcinoma.

Tekijät: Ye G; Department of Thoracic Surgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, No 55, Zhenhai Road, Xiamen, Fujian, 361003, China., Pan G; Department of Thoracic Surgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, No 55, Zhenhai Road, Xiamen, Fujian, 361003, China., Zhu X; Department of Thoracic Surgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, No 55, Zhenhai Road, Xiamen, Fujian, 361003, China., Liu H; Department of Thoracic Surgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, No 55, Zhenhai Road, Xiamen, Fujian, 361003, China., Li N; Department of Thoracic Surgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, No 55, Zhenhai Road, Xiamen, Fujian, 361003, China., Geng G; Department of Thoracic Surgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, No 55, Zhenhai Road, Xiamen, Fujian, 361003, China. ggj622@126.com., Jiang J; Department of Thoracic Surgery, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, No 55, Zhenhai Road, Xiamen, Fujian, 361003, China. jiangjie06@126.com.

Lähde: BMC gastroenterology [BMC Gastroenterol] 2025 Apr 04; Vol. 25 (1), pp. 223. Date of Electronic Publication: 2025 Apr 04.

Julkaisutyyppi: Journal Article

Lehden tiedot: Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X (Electronic) Linking ISSN: 1471230X NLM ISO Abbreviation: BMC Gastroenterol Subsets: MEDLINE

MeSH-termit: Esophageal Neoplasms*/therapy , Esophageal Neoplasms*/mortality , Esophageal Neoplasms*/pathology , Neoadjuvant Therapy* , Esophageal Squamous Cell Carcinoma*/therapy , Esophageal Squamous Cell Carcinoma*/mortality , Esophageal Squamous Cell Carcinoma*/pathology , Esophageal Squamous Cell Carcinoma*/surgery , Esophagectomy* , Immunotherapy*/methods , Time-to-Treatment*, Humans ; Male ; Female ; Middle Aged ; Prognosis ; Aged ; Time Factors ; Postoperative Complications/epidemiology ; Retrospective Studies ; Chemotherapy, Adjuvant ; Treatment Outcome ; Survival Rate

DCE-MRI radiomics of primary breast lesions combined with ipsilateral axillary lymph nodes for predicting efficacy of NAT.

Tekijät: Sun Y; School of Intelligent Medicine, China Medical University, Shenyang, Liaoning, 110122, P.R. China., Liao Q; School of Intelligent Medicine, China Medical University, Shenyang, Liaoning, 110122, P.R. China., Fan Y; Department of Biomedical Engineering, School of Information Science and Technology, Fudan University, Shanghai, 200082, P.R. China., Cui C; Department of Breast Imaging, Affiliated Hospital of Qingdao University, Qingdao, Shandong, 266100, P.R. China., Wang Y; School of Intelligent Medicine, China Medical University, Shenyang, Liaoning, 110122, P.R. China., Yang C; School of Intelligent Medicine, China Medical University, Shenyang, Liaoning, 110122, P.R. China., Hou Y; Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, 110004, P.R. China. houyang1973@163.com., Zhao D; Department of Medical Imaging, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, 110042, P.R. China. zhaodan777@126.com.

Lähde: BMC cancer [BMC Cancer] 2025 Apr 01; Vol. 25 (1), pp. 589. Date of Electronic Publication: 2025 Apr 01.

Julkaisutyyppi: Journal Article

Lehden tiedot: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

MeSH-termit: Breast Neoplasms*/diagnostic imaging , Breast Neoplasms*/pathology , Breast Neoplasms*/therapy , Breast Neoplasms*/drug therapy , Magnetic Resonance Imaging*/methods , Neoadjuvant Therapy*/methods , Lymph Nodes*/pathology , Lymph Nodes*/diagnostic imaging, Humans ; Female ; Middle Aged ; Retrospective Studies ; Axilla ; Adult ; Aged ; Nomograms ; ROC Curve ; Contrast Media ; Lymphatic Metastasis ; Radiomics ; Dynamic Contrast Enhanced Magnetic Resonance Imaging

A Comparison of neoadjuvant chemotherapy and concurrent chemoradiotherapy for for FIGO 2018 stage IB3/IIA2 Cervical squamous cell carcinoma: Long-term efficacy and safety in a resource-limited setting.

Tekijät: Xie R; Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shantou, P.R. China.; Shantou University Medical College, Shantou, P.R. China., Xie K; Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shantou, P.R. China.; Shantou University Medical College, Shantou, P.R. China., Lin X; Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shantou, P.R. China., Ji Y; Shantou University Medical College, Shantou, P.R. China., Chen J; Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shantou, P.R. China., Chen C; Department of Radiation Oncology, Cancer Hospital of Shantou University Medical College, Shantou, P.R. China.

Lähde: PloS one [PLoS One] 2025 Mar 25; Vol. 20 (3), pp. e0319405. Date of Electronic Publication: 2025 Mar 25 (Print Publication: 2025).

Julkaisutyyppi: Journal Article; Comparative Study

Lehden tiedot: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

MeSH-termit: Uterine Cervical Neoplasms*/therapy , Uterine Cervical Neoplasms*/pathology , Uterine Cervical Neoplasms*/mortality , Neoadjuvant Therapy*/methods , Neoadjuvant Therapy*/adverse effects , Chemoradiotherapy*/methods , Chemoradiotherapy*/adverse effects , Carcinoma, Squamous Cell*/therapy , Carcinoma, Squamous Cell*/pathology , Carcinoma, Squamous Cell*/mortality, Humans ; Female ; Middle Aged ; Neoplasm Staging ; Adult ; Aged ; Treatment Outcome ; Retrospective Studies ; Disease-Free Survival ; Resource-Limited Settings

Predicting anastomotic leak in patients with esophageal squamous cell cancer treated with neoadjuvant chemoradiotherapy using a nomogram based on CT radiomic and clinicopathologic factors.

Tekijät: Zhao J; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, No.440 Jiyan Road, Huaiyin District, Jinan, Shandong, People's Republic of China., Yang G; Department of Radiation Oncology, Shandong Second Provincial General Hospital, Jinan, Shandong, People's Republic of China., Li Y; Department of Medical Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China., Li S; Department of Oncology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong, China., Luo H; Department of Medical Oncology, Xiaogan Central Hospital, Xiaogan, Hubei, People's Republic of China., Han D; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, No.440 Jiyan Road, Huaiyin District, Jinan, Shandong, People's Republic of China., Li B; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, No.440 Jiyan Road, Huaiyin District, Jinan, Shandong, People's Republic of China. bsli@sdfmu.edu.cn., Cao Q; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, No.440 Jiyan Road, Huaiyin District, Jinan, Shandong, People's Republic of China. qiangcaochn@163.com.

Lähde: BMC cancer [BMC Cancer] 2025 Mar 15; Vol. 25 (1), pp. 484. Date of Electronic Publication: 2025 Mar 15.

Julkaisutyyppi: Journal Article

Lehden tiedot: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

MeSH-termit: Nomograms* , Neoadjuvant Therapy*/adverse effects , Neoadjuvant Therapy*/methods , Esophageal Squamous Cell Carcinoma*/therapy , Esophageal Squamous Cell Carcinoma*/pathology , Esophageal Squamous Cell Carcinoma*/diagnostic imaging , Anastomotic Leak*/etiology , Anastomotic Leak*/epidemiology , Anastomotic Leak*/diagnosis , Esophageal Neoplasms*/therapy , Esophageal Neoplasms*/pathology , Esophageal Neoplasms*/diagnostic imaging, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Esophagectomy/adverse effects ; Aged ; Tomography, X-Ray Computed/methods ; Chemoradiotherapy/adverse effects ; ROC Curve ; Adult ; Chemoradiotherapy, Adjuvant/adverse effects ; Radiomics

Prognostic role of STMN1 expression and neoadjuvant therapy efficacy in breast cancer.

Tekijät: Qian L; Thyroid and Breast Department, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, 9# Jinsui Road, Guangzhou, 510655, China.; Institute of Reproductive Health and Perinatology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China., Cairong Z; Thyroid and Breast Department, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, 9# Jinsui Road, Guangzhou, 510655, China.; Institute of Reproductive Health and Perinatology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China., Yongdong L; Thyroid and Breast Department, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, 9# Jinsui Road, Guangzhou, 510655, China.; Institute of Reproductive Health and Perinatology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China., Quan L; Thyroid and Breast Department, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, 9# Jinsui Road, Guangzhou, 510655, China.; Institute of Reproductive Health and Perinatology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China., Haihu Z; Thyroid and Breast Department, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, 9# Jinsui Road, Guangzhou, 510655, China.; Institute of Reproductive Health and Perinatology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China., Xiaofeng Z; Thyroid and Breast Department, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, 9# Jinsui Road, Guangzhou, 510655, China.; Institute of Reproductive Health and Perinatology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China., Xuan Y; Thyroid and Breast Department, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, 9# Jinsui Road, Guangzhou, 510655, China.; Institute of Reproductive Health and Perinatology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China., Yongcheng C; Department of Breast and Thyroid Surgery, Key Laboratory of Molecular Pathology in Tumors of Guangxi, Affiliated Hospital of Youjiang Medical University for Nationalities, Guangxi, China., Kai C; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.; Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China., Guanming L; Department of Breast and Thyroid Surgery, Key Laboratory of Molecular Pathology in Tumors of Guangxi, Affiliated Hospital of Youjiang Medical University for Nationalities, Guangxi, China., Jie L; Thyroid and Breast Department, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, 9# Jinsui Road, Guangzhou, 510655, China. lijie2958@gwcmc.org.; Institute of Reproductive Health and Perinatology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China. lijie2958@gwcmc.org.

Lähde: BMC cancer [BMC Cancer] 2025 Mar 13; Vol. 25 (1), pp. 453. Date of Electronic Publication: 2025 Mar 13.

Julkaisutyyppi: Journal Article

Lehden tiedot: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

MeSH-termit: Breast Neoplasms*/genetics , Breast Neoplasms*/drug therapy , Breast Neoplasms*/mortality , Breast Neoplasms*/pathology , Breast Neoplasms*/therapy , Neoadjuvant Therapy*/methods , Stathmin*/genetics , Stathmin*/metabolism , Biomarkers, Tumor*/genetics , Biomarkers, Tumor*/metabolism , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use, Humans ; Female ; Middle Aged ; Prognosis ; Adult ; Aged ; Gene Expression Regulation, Neoplastic ; Paclitaxel/therapeutic use ; Paclitaxel/administration & dosage ; Kaplan-Meier Estimate ; Docetaxel/therapeutic use ; Docetaxel/administration & dosage ; Chemotherapy, Adjuvant ; Treatment Outcome

Safety and efficacy of genomic biomarker-guided neoadjuvant therapy for locally advanced and oligometastatic prostate cancer (SEGNO): study protocol for an open-label prospective phase II umbrella clinical trial.

Tekijät: Huang H; Department of Urology, School of Medicine, The First Affiliated Hospital of Xiamen University, Xiamen University, 55 Zhenhai Road, Siming District, Xiamen, 361003, Fujian, China., Wang T; Department of Urology, School of Medicine, The First Affiliated Hospital of Xiamen University, Xiamen University, 55 Zhenhai Road, Siming District, Xiamen, 361003, Fujian, China., Li W; Department of Urology, School of Medicine, The First Affiliated Hospital of Xiamen University, Xiamen University, 55 Zhenhai Road, Siming District, Xiamen, 361003, Fujian, China., Wu Z; Department of Urology, School of Medicine, The First Affiliated Hospital of Xiamen University, Xiamen University, 55 Zhenhai Road, Siming District, Xiamen, 361003, Fujian, China., Wang X; Department of Urology, School of Medicine, The First Affiliated Hospital of Xiamen University, Xiamen University, 55 Zhenhai Road, Siming District, Xiamen, 361003, Fujian, China., Xing J; Department of Urology, School of Medicine, The First Affiliated Hospital of Xiamen University, Xiamen University, 55 Zhenhai Road, Siming District, Xiamen, 361003, Fujian, China., Chen B; Department of Urology, School of Medicine, The First Affiliated Hospital of Xiamen University, Xiamen University, 55 Zhenhai Road, Siming District, Xiamen, 361003, Fujian, China. chenbin5557@163.com.; The School of Clinical Medicine, Fujian Medical University, Fuzhou, 350122, Fujian, China. chenbin5557@163.com., Zhang K; Department of Urology, School of Medicine, The First Affiliated Hospital of Xiamen University, Xiamen University, 55 Zhenhai Road, Siming District, Xiamen, 361003, Fujian, China. Kaiyanzhang_xmu@163.com.; The School of Clinical Medicine, Fujian Medical University, Fuzhou, 350122, Fujian, China. Kaiyanzhang_xmu@163.com.

Lähde: BMC cancer [BMC Cancer] 2025 Mar 10; Vol. 25 (1), pp. 432. Date of Electronic Publication: 2025 Mar 10.

Julkaisutyyppi: Clinical Trial Protocol; Journal Article

Lehden tiedot: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

MeSH-termit: Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Biomarkers, Tumor*/genetics , Neoadjuvant Therapy*/methods , Prostatic Neoplasms*/genetics , Prostatic Neoplasms*/pathology , Prostatic Neoplasms*/drug therapy , Prostatic Neoplasms*/therapy , Prostatic Neoplasms*/mortality, Aged ; Humans ; Male ; Middle Aged ; Clinical Trials, Phase II as Topic ; Docetaxel/administration & dosage ; Genomics/methods ; Prospective Studies ; Treatment Outcome

Patients with macroscopic lymph node metastasis expect poor prognosis after neoadjuvant chemotherapy in advanced ovarian cancer: a retrospective cohort study based on a single gynecological team.

Tekijät: Guo W; Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shuaifuyuan 1#, Dongcheng District, Beijing, 100730, China., Yin J; Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shuaifuyuan 1#, Dongcheng District, Beijing, 100730, China., Gu Y; Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shuaifuyuan 1#, Dongcheng District, Beijing, 100730, China., Shan Y; Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shuaifuyuan 1#, Dongcheng District, Beijing, 100730, China., Wang W; Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shuaifuyuan 1#, Dongcheng District, Beijing, 100730, China., Li Y; Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shuaifuyuan 1#, Dongcheng District, Beijing, 100730, China., Qin M; Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shuaifuyuan 1#, Dongcheng District, Beijing, 100730, China., Chen J; Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shuaifuyuan 1#, Dongcheng District, Beijing, 100730, China., Jin Y; Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shuaifuyuan 1#, Dongcheng District, Beijing, 100730, China. jinying@pumch.cn., Pan L; Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shuaifuyuan 1#, Dongcheng District, Beijing, 100730, China.

Lähde: BMC cancer [BMC Cancer] 2025 May 06; Vol. 25 (1), pp. 832. Date of Electronic Publication: 2025 May 06.

Julkaisutyyppi: Journal Article

Lehden tiedot: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

MeSH-termit: Neoadjuvant Therapy* , Ovarian Neoplasms*/pathology , Ovarian Neoplasms*/drug therapy , Ovarian Neoplasms*/mortality , Ovarian Neoplasms*/surgery , Lymph Nodes*/pathology , Lymph Nodes*/surgery , Carcinoma, Ovarian Epithelial*/drug therapy , Carcinoma, Ovarian Epithelial*/pathology , Carcinoma, Ovarian Epithelial*/mortality, Humans ; Female ; Retrospective Studies ; Middle Aged ; Lymphatic Metastasis/pathology ; Prognosis ; Cytoreduction Surgical Procedures ; Aged ; Adult ; Lymph Node Excision ; Chemotherapy, Adjuvant ; Neoplasm Staging ; Neoplasm Recurrence, Local/pathology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use

Exploratory outcomes of the DHA WIN randomized controlled trial: Supplementing women with docosahexaenoic acid did not reduce the impact of neoadjuvant breast cancer chemotherapy on quality of life or exercise behaviour.

Tekijät: Douglas CM; Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada., Newell M; Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada., Goruk S; Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada., Courneya KS; Faculty of Kinesiology, Sport and Recreation, University of Alberta, Edmonton, Alberta, Canada., Ghosh S; Department of Oncology, University of Alberta, Edmonton, Alberta, Canada.; Department of Public Health Sciences, Henry Ford Hospital, Detroit, Michigan, United States of America., Joy AA; Department of Oncology, University of Alberta, Edmonton, Alberta, Canada., Munhoz J; Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada., Field CJ; Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada.

Lähde: PloS one [PLoS One] 2025 May 02; Vol. 20 (5), pp. e0322178. Date of Electronic Publication: 2025 May 02 (Print Publication: 2025).

Julkaisutyyppi: Journal Article; Randomized Controlled Trial

Lehden tiedot: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

MeSH-termit: Docosahexaenoic Acids*/administration & dosage , Docosahexaenoic Acids*/therapeutic use , Breast Neoplasms*/drug therapy , Quality of Life* , Neoadjuvant Therapy* , Dietary Supplements* , Exercise*, Humans ; Female ; Middle Aged ; Adult ; Aged ; Treatment Outcome

Effect of perioperative probiotic supplements on the short-term clinical outcomes of patients undergoing laparoscopic or robotic radical gastrectomy after neoadjuvant chemotherapy: Study protocol for a multicenter randomized controlled trial (GISSG2023 - 01 Study).

Tekijät: Liu G; Department of Gastrointestinal Surgery, the Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, China., Cao S; Department of Gastrointestinal Surgery, the Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, China., Liu X; Department of Gastrointestinal Surgery, the Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, China., Tian Y; Department of Gastrointestinal Surgery, the Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, China., Yu W; Qilu Hospital of Shandong University, Jinan, China., Chai J; Shandong Cancer Hospital, Jinan, China., Li L; Shandong Provincial Hospital, Jinan, China., Wang X; Yantai Yuhuangding Hospital, Yantai, China., Chu X; Shandong Jining No.1 People's Hospital, Jining, China., Duan Q; Affiliated Hospital of Weifang Medical University, Weifang, China., Qu J; Weifang People's Hospital, Weifang, China., Wang H; Dongying People's Hospital, Dongying, China., Zhang H; Weihai Municipal Hospital, Weihai, China., Wang X; Weihai Central Hospital, Weihai, China., Hui X; Rizhao People's Hospital, Rizhao, China., Yang D; Liaocheng People's Hospital, Liaocheng, China., Zhou S; Qingdao Municipal Hospital, Qingdao, China., Ding Y; The Second Hospital of Shandong University, Jinan, China., Wang H; The People's Hospital of Jimo, Qingdao, China., Zhou F; Binzhou People's Hospital, Binzhou, China., Hu B; Binzhou Medical University Hospital, Yantai, China., Guo P; Jinan Central Hospital, Jinan, China., Jiang L; Yantai Yeda Hospital, Yantai, China., Zhang G; Shandong Provincial Qianfoshan Hospital, Jinan, China., Pan Q; Rushan People's Hospital, Weihai, China., Zhou X; Department of Epidemiology and Health Statistics, School of Public Health of Qingdao University, Qingdao, China., Zhou Y; Department of Gastrointestinal Surgery, the Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, China. zhouyanbing@qduhospital.cn.

Lähde: BMC cancer [BMC Cancer] 2025 Apr 25; Vol. 25 (1), pp. 776. Date of Electronic Publication: 2025 Apr 25.

Julkaisutyyppi: Journal Article; Clinical Trial Protocol

Lehden tiedot: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

MeSH-termit: Probiotics*/administration & dosage , Probiotics*/therapeutic use , Stomach Neoplasms*/surgery , Stomach Neoplasms*/drug therapy , Stomach Neoplasms*/therapy , Stomach Neoplasms*/pathology , Gastrectomy*/methods , Gastrectomy*/adverse effects , Neoadjuvant Therapy*/methods , Laparoscopy*/methods , Laparoscopy*/adverse effects , Robotic Surgical Procedures*/methods , Robotic Surgical Procedures*/adverse effects, Humans ; Multicenter Studies as Topic ; Randomized Controlled Trials as Topic ; Treatment Outcome ; Prospective Studies ; Female ; Male ; Middle Aged ; Perioperative Care/methods ; Postoperative Complications/prevention & control

NEoAdjuvant radiohormonal therapy versus standard of care for oligometastatic prostate cancer (NEAR-TOP): study protocol of a multicenter, open-label, randomised controlled trial.

Tekijät: Fan Z; Department of Urology, The Second Affiliated Hospitalof Naval Medical Uiversity, 415 Fengyang Road, Shanghai, 200433, China., Li D; Department of Urology, The Second Affiliated Hospitalof Naval Medical Uiversity, 415 Fengyang Road, Shanghai, 200433, China., Yan S; Department of Urology, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, China., Zhao X; Department of Radiation Oncology, The First Affiliated Hospital of Naval Medical Uiversity, 168 Changhai Road, Shanghai, 200433, China.; Department of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, 215000, China., Yin L; Department of Urology, The Second Affiliated Hospitalof Naval Medical Uiversity, 415 Fengyang Road, Shanghai, 200433, China., Xu W; Department of Urology, The Second Affiliated Hospitalof Naval Medical Uiversity, 415 Fengyang Road, Shanghai, 200433, China., Wang Y; Department of Urology, The Second Affiliated Hospitalof Naval Medical Uiversity, 415 Fengyang Road, Shanghai, 200433, China., Zhang H; Department of Radiation Oncology, The First Affiliated Hospital of Naval Medical Uiversity, 168 Changhai Road, Shanghai, 200433, China. huojunzh@163.com., Chang Y; Department of Urology, The First Affiliated Hospital of Naval Medical Uiversity, 168 Changhai Road, Shanghai, 200433, China. 13661652533@163.com., Ren S; Department of Urology, The Second Affiliated Hospitalof Naval Medical Uiversity, 415 Fengyang Road, Shanghai, 200433, China. renshancheng@gmail.com.

Lähde: BMC cancer [BMC Cancer] 2025 Apr 24; Vol. 25 (1), pp. 768. Date of Electronic Publication: 2025 Apr 24.

Julkaisutyyppi: Clinical Trial Protocol; Journal Article

Lehden tiedot: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

MeSH-termit: Neoadjuvant Therapy*/methods , Prostatic Neoplasms*/pathology , Prostatic Neoplasms*/therapy , Prostatic Neoplasms*/mortality, Aged ; Humans ; Male ; Androstenes/administration & dosage ; Androstenes/therapeutic use ; Gonadotropin-Releasing Hormone/therapeutic use ; Gonadotropin-Releasing Hormone/administration & dosage ; Multicenter Studies as Topic ; Neoplasm Metastasis ; Prospective Studies ; Prostatectomy/methods ; Radiotherapy, Intensity-Modulated/methods ; Randomized Controlled Trials as Topic ; Standard of Care

Dismal pathological response to neoadjuvant chemotherapy in stage III breast cancer patients in Tanzania: A retrospective review.

Tekijät: Kivuyo N; Department of Surgery, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Akoko L; Department of Surgery, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Mutajwaha JOG; Department of Surgery, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Haule C; Department of Surgery, Muhimbili National Hospital, Dar es Salaam, Tanzania., Mosha I; Department of Pathology, Muhimbili National Hospital, Dar-es-Salaam, Tanzania., Misidai M; Department of Surgery, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Kitua D; Department of Surgery, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Nyongole O; Department of Surgery, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Mwanga A; Department of Surgery, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.

Lähde: PloS one [PLoS One] 2025 Apr 23; Vol. 20 (4), pp. e0321187. Date of Electronic Publication: 2025 Apr 23 (Print Publication: 2025).

Julkaisutyyppi: Journal Article

Lehden tiedot: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

MeSH-termit: Neoadjuvant Therapy*/methods , Breast Neoplasms*/pathology , Breast Neoplasms*/drug therapy, Humans ; Female ; Retrospective Studies ; Tanzania/epidemiology ; Middle Aged ; Adult ; Neoplasm Staging ; Aged ; Mastectomy ; Chemotherapy, Adjuvant ; Treatment Outcome

Efficacy and safety of XELOX combined with neoadjuvant radiotherapy versus neoadjuvant chemotherapy in locally advanced gastric cancer.

Tekijät: Bu S; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China., Wang S; Department of Surgical Oncology and General Surgery, The First Affiliated Hospital of China Medical University, Shenyang, China., Wang T; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China., Xing H; Department of Surgery, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI, 02903, USA., Cao Y; Department of Pathology, Affiliated Hospital of Nantong University, Nantong, 22600, China., Zhang Z; Department of General Surgery, The Affiliated Tumor Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China., Shang C; Department of General Surgery, The Affiliated Tumor Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China., Tang X; Department of Medical Record, The Affiliated Tumor Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China., Liu Y; Department of Pathology, Affiliated Hospital of Nantong University, Nantong, 22600, China. ntdxliuyifei@sina.com., Dong X; Precision Health Program, Department of Radiology, College of Human Medicine, Michigan State University, East Lansing, MI, 48824, USA. dongxi19@msu.edu., Wang X; Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China. wangxiushen1218@163.com.

Lähde: BMC cancer [BMC Cancer] 2025 Apr 18; Vol. 25 (1), pp. 731. Date of Electronic Publication: 2025 Apr 18.

Julkaisutyyppi: Journal Article; Comparative Study

Lehden tiedot: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

MeSH-termit: Stomach Neoplasms*/therapy , Stomach Neoplasms*/pathology , Capecitabine*/therapeutic use , Capecitabine*/administration & dosage , Capecitabine*/adverse effects , Neoadjuvant Therapy*/methods , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects, Humans ; Male ; Female ; Middle Aged ; Oxaloacetates/therapeutic use ; Retrospective Studies ; Aged ; Gastrectomy ; Treatment Outcome ; Adult ; Chemoradiotherapy, Adjuvant/methods ; Lymph Node Excision

SCR Protocol: XELOX

Neoadjuvant Therapy and Lung Cancer: Role of Pathologists.

Tekijät: Dacic S; From the Department of Pathology, Yale School of Medicine, New Haven, Connecticut.

Lähde: Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2025 Apr 01; Vol. 149 (4), pp. e78-e81.

Julkaisutyyppi: Journal Article; Review

Lehden tiedot: Publisher: College of American Pathologists Country of Publication: United States NLM ID: 7607091 Publication Model: Print Cited Medium: Internet ISSN: 1543-2165 (Electronic) Linking ISSN: 00039985 NLM ISO Abbreviation: Arch Pathol Lab Med Subsets: MEDLINE

MeSH-termit: Neoadjuvant Therapy*/methods , Lung Neoplasms*/pathology , Lung Neoplasms*/therapy , Lung Neoplasms*/drug therapy , Lung Neoplasms*/surgery , Pathologists* , Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/therapy , Carcinoma, Non-Small-Cell Lung*/drug therapy, Humans

Predictors of pathological complete response after total neoadjuvant treatment using short course radiotherapy for locally advanced rectal cancer.

Tekijät: Yacoub H; Gastroenterolgy department, La Rabta Hospital, Tunis, Tunisia. yacoubhaythem@hotmail.com.; Faculty of Medicine of Tunis, El Manar university, Tunis, Tunisia. yacoubhaythem@hotmail.com., Zenzri Y; Oncology department, Salah Azaiez Institute, Tunis, Tunisia.; Faculty of Medicine of Tunis, El Manar university, Tunis, Tunisia., Cherif D; Gastroenterolgy department, La Rabta Hospital, Tunis, Tunisia.; Faculty of Medicine of Tunis, El Manar university, Tunis, Tunisia., Ben Mansour H; Oncology department, Salah Azaiez Institute, Tunis, Tunisia.; Faculty of Medicine of Tunis, El Manar university, Tunis, Tunisia., Attia N; Radiotherapy department, Salah Azaiez Institute, Tunis, Tunisia.; Faculty of Medicine of Tunis, El Manar university, Tunis, Tunisia., Mokrani C; Radiotherapy department, Salah Azaiez Institute, Tunis, Tunisia.; Faculty of Medicine of Tunis, El Manar university, Tunis, Tunisia., Ben Zid K; Radiotherapy department, Salah Azaiez Institute, Tunis, Tunisia.; Faculty of Medicine of Tunis, El Manar university, Tunis, Tunisia., Letaief F; Oncology department, Salah Azaiez Institute, Tunis, Tunisia.; Faculty of Medicine of Tunis, El Manar university, Tunis, Tunisia., Maamouri N; Oncology department, Salah Azaiez Institute, Tunis, Tunisia.; Faculty of Medicine of Tunis, El Manar university, Tunis, Tunisia., Mezlini A; Oncology department, Salah Azaiez Institute, Tunis, Tunisia.; Faculty of Medicine of Tunis, El Manar university, Tunis, Tunisia.

Lähde: BMC gastroenterology [BMC Gastroenterol] 2025 Mar 31; Vol. 25 (1), pp. 208. Date of Electronic Publication: 2025 Mar 31.

Julkaisutyyppi: Journal Article

Lehden tiedot: Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X (Electronic) Linking ISSN: 1471230X NLM ISO Abbreviation: BMC Gastroenterol Subsets: MEDLINE

MeSH-termit: Rectal Neoplasms*/pathology , Rectal Neoplasms*/therapy , Neoadjuvant Therapy*/methods, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Aged ; Treatment Outcome ; Chemoradiotherapy, Adjuvant

Effect of Helicobacter pylori infection on survival outcomes of patients undergoing radical gastrectomy after neoadjuvant chemotherapy: a multicenter study in China.

Tekijät: He QC; Department of Gastric Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Rd, Fuzhou, 350001, Fujian Province, China.; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, China.; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China.; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China., Huang ZN; Department of Gastric Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Rd, Fuzhou, 350001, Fujian Province, China.; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, China.; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China.; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China., Lv CB; Department of Gastrointestinal Surgery, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, China., Wu YH; Department of Pathology, Zhangzhou Affiliated Hospital of Fujian Medical University, ZhangZhou, China., Qiu WW; Department of Gastric Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Rd, Fuzhou, 350001, Fujian Province, China.; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, China.; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China.; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China., Ma YB; Department of Gastrointestinal Surgery, Qinghai University Affiliated Hospital, Xining, China., Wu J; Department of Gastric Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Rd, Fuzhou, 350001, Fujian Province, China.; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, China.; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China.; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China.; Department of General Surgery, Affiliated Zhongshan Hospital of Dalian University, Dalian, China., Zheng CY; Department of Gastric Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Rd, Fuzhou, 350001, Fujian Province, China.; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, China.; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China.; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China.; Department of Gastrointestinal Surgery, The Affiliated Hospital of Putian University, Putian, China., Lin GS; Department of Gastric Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Rd, Fuzhou, 350001, Fujian Province, China.; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, China.; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China.; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China., Li P; Department of Gastric Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Rd, Fuzhou, 350001, Fujian Province, China.; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, China.; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China.; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China., Wang JB; Department of Gastric Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Rd, Fuzhou, 350001, Fujian Province, China.; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, China.; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China.; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China., Lin JX; Department of Gastric Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Rd, Fuzhou, 350001, Fujian Province, China.; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, China.; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China.; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China., Lin M; Department of Gastric Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Rd, Fuzhou, 350001, Fujian Province, China.; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, China.; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China.; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China., Tu RH; Department of Gastric Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Rd, Fuzhou, 350001, Fujian Province, China.; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, China.; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China.; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China., Zheng CH; Department of Gastric Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Rd, Fuzhou, 350001, Fujian Province, China.; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, China.; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China.; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China., Huang CM; Department of Gastric Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Rd, Fuzhou, 350001, Fujian Province, China. hcmlr2002@163.com.; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, China. hcmlr2002@163.com.; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China. hcmlr2002@163.com.; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China. hcmlr2002@163.com., Cao LL; Department of Gastric Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Rd, Fuzhou, 350001, Fujian Province, China. 1291821982@qq.com.; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, China. 1291821982@qq.com.; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China. 1291821982@qq.com.; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China. 1291821982@qq.com., Xie JW; Department of Gastric Surgery, Fujian Medical University Union Hospital, No. 29 Xinquan Rd, Fuzhou, 350001, Fujian Province, China. xjwhw2019@163.com.; Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, China. xjwhw2019@163.com.; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China. xjwhw2019@163.com.; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, China. xjwhw2019@163.com.

Lähde: BMC cancer [BMC Cancer] 2025 Mar 13; Vol. 25 (1), pp. 460. Date of Electronic Publication: 2025 Mar 13.

Julkaisutyyppi: Journal Article; Multicenter Study

Lehden tiedot: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

MeSH-termit: Gastrectomy*/mortality , Stomach Neoplasms*/mortality , Stomach Neoplasms*/pathology , Stomach Neoplasms*/microbiology , Stomach Neoplasms*/therapy , Stomach Neoplasms*/surgery , Stomach Neoplasms*/drug therapy , Helicobacter Infections*/complications , Helicobacter Infections*/mortality , Helicobacter Infections*/microbiology , Neoadjuvant Therapy* , Helicobacter pylori*/isolation & purification, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; China/epidemiology ; Aged ; Prognosis ; Chemotherapy, Adjuvant ; Adult ; Neoplasm Staging

Advances in analytical approaches for background parenchymal enhancement in predicting breast tumor response to neoadjuvant chemotherapy: A systematic review.

Tekijät: Thomas J; School of Computing and Engineering Sciences, Strathmore University, Nairobi, Kenya., Malla L; London School of Hygiene & Tropical Medicine, London, United Kingdom., Shibwabo B; School of Computing and Engineering Sciences, Strathmore University, Nairobi, Kenya.

Lähde: PloS one [PLoS One] 2025 Mar 07; Vol. 20 (3), pp. e0317240. Date of Electronic Publication: 2025 Mar 07 (Print Publication: 2025).

Julkaisutyyppi: Journal Article; Systematic Review

Lehden tiedot: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

MeSH-termit: Breast Neoplasms*/drug therapy , Breast Neoplasms*/diagnostic imaging , Breast Neoplasms*/pathology , Neoadjuvant Therapy*/methods , Magnetic Resonance Imaging*/methods, Humans ; Female ; Contrast Media

Comprehensive evaluation of tumor response better evaluates the efficacy of neoadjuvant chemotherapy and predicts the prognosis in gastric cancer - a post hoc analysis of a single-center randomized controlled trial.

Tekijät: Gan X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), gastrointestinal surgery of department, Peking University Cancer Hospital & Institute, Beijing, 100142, China., Jia Y; State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, gastrointestinal surgery of department, Peking University Cancer Hospital & Institute, Beijing, 100142, China., Shan F; State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, gastrointestinal surgery of department, Peking University Cancer Hospital & Institute, Beijing, 100142, China., Ying X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), gastrointestinal surgery of department, Peking University Cancer Hospital & Institute, Beijing, 100142, China., Li S; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), gastrointestinal surgery of department, Peking University Cancer Hospital & Institute, Beijing, 100142, China., Zhang Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), gastrointestinal surgery of department, Peking University Cancer Hospital & Institute, Beijing, 100142, China., Pang F; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), gastrointestinal surgery of department, Peking University Cancer Hospital & Institute, Beijing, 100142, China., Li Z; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), gastrointestinal surgery of department, Peking University Cancer Hospital & Institute, Beijing, 100142, China. ziyu_li@hsc.pku.edu.cn.

Lähde: BMC cancer [BMC Cancer] 2025 Mar 05; Vol. 25 (1), pp. 401. Date of Electronic Publication: 2025 Mar 05.

Julkaisutyyppi: Journal Article; Randomized Controlled Trial

Lehden tiedot: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

MeSH-termit: Stomach Neoplasms*/drug therapy , Stomach Neoplasms*/pathology , Stomach Neoplasms*/mortality , Neoadjuvant Therapy*/methods , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use, Humans ; Female ; Male ; Middle Aged ; Prognosis ; Aged ; Gastrectomy ; Adult ; Chemotherapy, Adjuvant ; Treatment Outcome ; Biomarkers, Tumor ; Tomography, X-Ray Computed ; Prospective Studies

Assessment of quality of life, pain, depression, and body-image in breast cancer patients in neoadjuvant therapy.

Tekijät: Vieira Carvalho A; Mater´s Program in Health Sciences, Faculty of Medical Sciences of Minas Gerais, Belo Horizonte, Brazil.; Institute of Clinical Oncology, Santa Casa de Belo Horizonte, Belo Horizonte, Brazil., Lima Barroso VF; School of Medicine, Faculty of Medical Sciences of Minas Gerais, Belo Horizonte, Brazil., Lobo Baeta CC; Institute of Clinical Oncology, Santa Casa de Belo Horizonte, Belo Horizonte, Brazil., Soares AN; Mater´s Program in Health Sciences, Faculty of Medical Sciences of Minas Gerais, Belo Horizonte, Brazil., Drummond-Lage AP; Mater´s Program in Health Sciences, Faculty of Medical Sciences of Minas Gerais, Belo Horizonte, Brazil.

Lähde: Psychology, health & medicine [Psychol Health Med] 2025 Feb; Vol. 30 (2), pp. 325-340. Date of Electronic Publication: 2024 Nov 20.

Julkaisutyyppi: Journal Article; Observational Study

Lehden tiedot: Publisher: Routledge Country of Publication: England NLM ID: 9604099 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1465-3966 (Electronic) Linking ISSN: 13548506 NLM ISO Abbreviation: Psychol Health Med Subsets: MEDLINE

MeSH-termit: Quality of Life*/psychology , Breast Neoplasms*/psychology , Breast Neoplasms*/drug therapy , Breast Neoplasms*/therapy , Body Image*/psychology , Neoadjuvant Therapy*/psychology , Neoadjuvant Therapy*/adverse effects , Depression*/psychology, Humans ; Female ; Middle Aged ; Longitudinal Studies ; Adult ; Brazil ; Aged

Predictive factors for axillary pathological complete response to neoadjuvant therapy in elderly breast cancer patients.

Tekijät: Wang Y; School of Medicine, University of Electronic Science and Technology of China, Chengdu, China., Wang R; College of Clinical Medicine, North Sichuan Medical College, Nanchong, Sichuan, 637000, China., Lu D; School of Medicine, University of Electronic Science and Technology of China, Chengdu, China., Zeng Y; School of Medicine, University of Electronic Science and Technology of China, Chengdu, China., Tu X; College of Clinical Medicine, North Sichuan Medical College, Nanchong, Sichuan, 637000, China., Liu S; Department of Breast, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute,Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China. shiweiliu-lsw@outlook.com., Zhang P; Department of Breast, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute,Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China. zprrong123321@163.com.

Lähde: BMC cancer [BMC Cancer] 2025 Jan 27; Vol. 25 (1), pp. 156. Date of Electronic Publication: 2025 Jan 27.

Julkaisutyyppi: Journal Article

Lehden tiedot: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

MeSH-termit: Breast Neoplasms*/pathology , Breast Neoplasms*/therapy , Breast Neoplasms*/drug therapy , Neoadjuvant Therapy*/methods , Lymph Nodes*/pathology, Humans ; Female ; Aged ; Axilla/pathology ; Retrospective Studies ; Receptor, ErbB-2/metabolism ; Aged, 80 and over ; Lymphatic Metastasis ; Neoplasm Staging ; Lymph Node Excision ; Treatment Outcome ; Prognosis